https://pharminent.com/strategic-news-watch/strategic-news-watch-may-29-2026/ 2026-05-29T19:35:15Z Pharminent en Strategic News Watch • May 29, 2026 2026-05-29T19:35:11Z Blog https://pharminent.com/asco-bms-hails-compelling-phase-3-celmod-readout/ 2026-05-29T17:19:02Z Pharminent en ASCO: BMS hails "compelling" phase 3 celmod readout 2026-05-29T15:20:45Z Blog https://pharminent.com/summits-pd-1-vegf-to-take-center-stage-at-asco-with-wide-impact-for-peers/ 2026-05-29T17:19:07Z Pharminent en Summit's PD-1/VEGF to take center stage at ASCO, with wide impact for peers 2026-05-29T14:17:35Z Blog https://pharminent.com/pfizer-bets-up-to-10-5b-in-12-candidate-cancer-collab-with-chinas-innovent/ 2026-05-29T17:19:09Z Pharminent en Pfizer bets up to $10.5B in 12-candidate cancer collab with China's Innovent 2026-05-29T11:04:01Z Blog https://pharminent.com/gsks-nucala-secures-nice-copd-endorsement/ 2026-05-29T21:23:52Z Pharminent en GSK's Nucala secures NICE COPD endorsement 2026-05-29T10:26:43Z Blog https://pharminent.com/ahead-of-asco-data-drop-az-gets-key-imfinzi-approval/ 2026-05-29T17:19:11Z Pharminent en Ahead of ASCO data drop, AZ gets key Imfinzi approval 2026-05-29T10:01:58Z Blog https://pharminent.com/rare-disease-gene-therapy/rare-disease-gene-therapy-digest-may-28-2026/ 2026-05-29T02:44:03Z Pharminent en Rare Disease & Gene Therapy Digest • May 28, 2026 2026-05-29T02:43:59Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-may-28-2026/ 2026-05-28T18:43:55Z Pharminent en Strategic News Watch • May 28, 2026 2026-05-28T18:43:50Z Blog https://pharminent.com/medicare-advantage-out-of-pocket-limits-variation-and-trends/ 2026-05-29T17:30:21Z Pharminent en Medicare Advantage Out-of-Pocket Limits: Variation and Trends 2026-05-28T17:17:28Z Blog https://pharminent.com/gsk-ionis-unveil-data-for-hepatitis-b-drug-touted-as-functional-cure/ 2026-05-29T17:30:32Z Pharminent en GSK, Ionis unveil data for hepatitis B drug touted as 'functional cure' 2026-05-28T16:01:00Z Blog https://pharminent.com/cvs-obesity-drug-deal-puts-lilly-on-equal-footing-with-novo/ 2026-05-28T15:34:46Z Pharminent en CVS obesity drug deal puts Lilly on equal footing with Novo 2026-05-28T15:09:00Z Blog https://pharminent.com/france-first-eu-country-to-cover-obesity-drugs/ 2026-05-29T21:24:34Z Pharminent en France 'first EU country to cover obesity drugs' 2026-05-28T13:11:36Z Blog https://pharminent.com/gsk-hails-unprecedented-cure-rates-with-hep-b-drug/ 2026-05-28T15:34:52Z Pharminent en GSK hails 'unprecedented' cure rates with hep B drug 2026-05-28T12:05:56Z Blog https://pharminent.com/abbvie-snags-fdas-first-adc-approval-for-ultra-rare-blood-cancer/ 2026-05-28T15:34:56Z Pharminent en AbbVie snags FDA's first ADC approval for ultra-rare blood cancer 2026-05-28T11:27:47Z Blog https://pharminent.com/neuromarket-pulse/neuromarket-pulse-weekly-neuroscience-competitive-intelligence-may-27-2026/ 2026-05-27T22:27:25Z Pharminent en NeuroMarket Pulse • Weekly Neuroscience Competitive Intelligence • May 27, 2026 2026-05-27T22:27:21Z Blog https://pharminent.com/manufacturing-intelligence/manufacturing-intelligence-weekly-digest-may-27-2026/ 2026-05-27T21:49:02Z Pharminent en Manufacturing Intelligence • Weekly Digest • May 27, 2026 2026-05-27T21:48:59Z Blog https://pharminent.com/81130-2/ 2026-05-27T21:43:03Z Pharminent en 2026-05-27T21:42:57Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-may-27-2026/ 2026-05-27T17:31:58Z Pharminent en Strategic News Watch • May 27, 2026 2026-05-27T17:31:53Z Blog https://pharminent.com/apogee-investors-riled-by-1-3b-royalty-deal-as-eczema-drug-matches-lillys-ebglyss/ 2026-05-27T16:09:42Z Pharminent en Apogee investors riled by $1.3B royalty deal, as eczema drug matches Lilly's Ebglyss 2026-05-27T15:15:18Z Blog https://pharminent.com/kardigan-targets-ipo-to-support-cardiology-pipeline-progression/ 2026-05-27T16:09:48Z Pharminent en Kardigan targets IPO to support cardiology pipeline progression 2026-05-27T14:06:51Z Blog https://pharminent.com/fda-delays-verdict-on-az-breast-cancer-drug/ 2026-05-27T16:09:52Z Pharminent en FDA delays verdict on AZ breast cancer drug 2026-05-27T12:47:03Z Blog https://pharminent.com/oncology/oncology-intelligence-digest-may-26-2026/ 2026-05-27T01:14:59Z Pharminent en Oncology Intelligence Digest • May 26, 2026 2026-05-27T01:14:56Z Blog